Reprise Biomedical
BioTech/Drugs - Plymouth, MN - Minne, N/A
Reprise Biomedical Employees
Reprise Biomedical Senior Management
Reprise Biomedical Details
Reprise Biomedical, Inc. is a Minnesota-based startup focused on commercializing biological medical devices manufactured using a proprietary perfusion decellularization technology that supports cellular integration. Reprise was created in connection with a spin-off from Miromatrix Medical Inc. in June 2019. Through the spin-off, Miromatrix transferred to Reprise two existing FDA 510(k) cleared, commercially available medical devices – MiroMesh® Biologic Matrix and MiroDerm® Biologic Wound Matrix – as well as all acellular medical devices in development.MiroMesh and MiroDerm are derived via perfusion decellularization of the highly vascularized porcine liver. A non-crosslinked surgical matrix, MiroMesh comes in a variety of sizes suited for hernia repair applications. MiroDerm is indicated for the management of wounds, including diabetic foot ulcers, venous ulcers, pressure ulcers, and surgical and trauma wounds.
Reprise Biomedical Technologies
Email Providers
Mimecast
Marketing Automation
Hubspot
CMS
WordPress.org
Hosted Forms
Gravity Forms
Email Delivery
Mailchimp Mandrill
Other
Microsoft Office 365